Budoneb 0,25 mg/ml & 0,5 mg/ml Film-coated tablets.

Indication

Management of asthma and acute laryngotracheobronchitis in children.

Dosage (summary)

Adults: 0.5-1 mg twice daily; Children: 0.25-1 mg twice daily based on previous therapy.

Onset of Action / Duration

Onset: 10-30 mins, Duration: 2-3 hours

Special Populations

• Children under 12 months
• Renal impairment
• Hepatic impairment

Pregnancy & Breastfeeding

Safety in pregnancy and lactation not established.

Key Drug Interactions

• CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)

Contraindications

• Hypersensitivity to budesonide
• Lung tuberculosis
• Fungal and viral infections

Common side effects

• Oral thrush
• Hoarseness
• Coughing
• Cataract
• Skin bruising

Counselling Points

• Rinse mouth after use
• Wash face after nebuliser use
• Monitor for signs of adrenal insufficiency